Niquitin Tropische Früchte (Nicotine Resinate)

Nicotine resinate is indicated for nicotine‑related disorders, primarily to support cessation of tobacco use.

• Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while attempting to quit.
• Tobacco dependence: provides a controlled nicotine dose to replace cigarettes and facilitate gradual reduction.
• Relapse prevention: can be used after initial quitting to maintain abstinence and lower the risk of returning to smoking.

• Nicotine resinate acts as a partial agonist at neuronal nicotinic acetylcholine receptors, especially the α4β2 subtype. By stimulating these receptors, it delivers a modest nicotine signal that reduces the intensity of withdrawal while allowing the brain to adapt, thereby easing the transition away from combustible tobacco use.

Adverse reactions may occur with oromucosal nicotine replacement products.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Nausea: transient feeling of queasiness.
• Headache: mild to moderate intensity.
• Dyspepsia: upset stomach or indigestion.
• Dizziness: temporary light‑headedness.
• Increased salivation: excess saliva production.

Serious or Rare Side Effects

• Cardiovascular events: chest pain, palpitations, or hypertension.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Persistent vomiting: prolonged emesis requiring medical attention.
• Hypotension: marked drop in blood pressure.
• Seizures: rare convulsive episodes.
• Respiratory distress: severe shortness of breath.

When considering nicotine resinate, certain safety measures should be observed.

• Cardiovascular assessment: evaluate history of heart disease before initiating therapy.
• Pregnancy status: avoid use unless benefits outweigh potential risks.
• Breastfeeding: consider potential nicotine exposure to infant.
• Concomitant nicotine products: do not combine with other nicotine‑containing items.
• Age restriction: intended for adult use only.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Nicotine resinate may interact with other medications or substances.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis.
• Beta‑blockers: may blunt cardiovascular response to nicotine.

Moderate Interactions (Monitor Closely)

• CYP2A6 substrates (e.g., bupropion): altered nicotine metabolism.
• Antidepressants (SSRIs, SNRIs): potential for additive central nervous system effects.
• Caffeine: may enhance stimulant effects, leading to jitteriness.
• Alcohol: combined use can increase cardiovascular strain.